News | Stem Cell Therapies
June 12, 2017 — Heart muscle is one of the least renewable tissues in the body, which is one of the reasons that heart ...
June 12, 2017
News | Cardiovascular Ultrasound
June 12, 2017 — A study using strain imaging presented at the American Society of Echocardiography (ASE) 2017 ...
June 12, 2017
News
June 12, 2017 – The Medtronic Resolute Onyx Drug-Eluting Stent (DES) met its primary endpoint of target lesion failure ...
June 12, 2017Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Feature | Heart Valve Technology
June 5, 2017 – The U.S. Food and Drug Administration (FDA) granted market clearance for the Claret Medical Sentinel ...
June 09, 2017
Videos | Cardiovascular Ultrasound
Chi-Ming Chow, M.D., MSc, FRCPC, FACC, FASE, attending staff cardiologist, St. Michael's Hospital, and associate professor, Department of Medicine, University of Toronto, discusses new technology trends in ultrasound and what developments will effect the future of cardiac ultrasound.
June 07, 2017
Videos | Cardiovascular Business
Andrea Natale, M.D., FACC, FHRS, FESC, executive medical director, Texas Cardiac Arrhythmia Institute at St. David's ...
June 06, 2017Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Feature | Heart Valve Technology | Dave Fornell
The U.S. Food and Drug Administration (FDA) has granted market clearance for aortic and mitral valve-in-valve procedures using the Edwards Lifesciences Sapien 3 transcatheter heart valve (THV). The Sapien 3 valve is the first transcatheter heart valve approved in the U.S. for the treatment of both aortic and mitral patients who are at high risk for a subsequent open-heart surgery to replace their bioprosthetic valve.
June 06, 2017
News | Cardiovascular Ultrasound
June 1, 2017 — More than 50 companies and organizations will display their latest products and services at the American ...
June 01, 2017
Feature | Dave Fornell
June 1, 2017 — Here is the list of the most popular pieces of content on the Diagnostic and Interventional Cardiology ...
June 01, 2017Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News | Wearables
Northwell Health recently announced a new partnership agreement with Peerbridge Health Inc., to explore the future of remote medical monitoring. Peerbridge technology enables remote patient monitoring through multiple on-body wireless sensors.
June 01, 2017
Technology | Radiation Dose Management
June 1, 2017 — Infab Corp. recently introduced Revolution Lead and Lead-Free Aprons with Kiarmor, Infab’s proprietary bi ...
June 01, 2017
Lucas Boersma, M.D., Ph.D., FESC, St. Antonius Ziekenhuis, Nieuwegein, The Netherlands, discusses how subcutaneous ...
June 01, 2017Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Feature | ASE
ASE Announces Meeting Highlights for 28th Annual Scientific Sessions — The program includes learning opportunities from ...
June 01, 2017
News | Heart Valve Technology
LivaNova PLC recently announced the presentation of data from multiple studies demonstrating the safety and effectiveness of the PercevalM sutureless valve for aortic valve replacement (AVR) patients and the Memo 3D ReChord for mitral valve repair. The three data presentations on Perceval, which included a late-breaking clinical trial and a poster presentation on the Memo 3D ReChord, were unveiled at the American Association for Thoracic Surgery (AATS) Centennial meeting in Boston, April 29 – May 3.
May 31, 2017
News | FFR Technologies
Acist Medical Systems Inc. announced results from the ACIST-FFR Study demonstrating the consistent and correlative performance of the Navvus MicroCatheter compared to standard pressure wire systems. ACIST-FFR (Assessment of Catheter-based Interrogation and Standard Techniques for Fractional Flow Reserve measurement) is the largest multi-center study to compare microcatheter FFR to pressure wire FFR, as well as the only study to include multiple pressure wire comparators. The study was presented for the first time at EuroPCR 2017, May 16-19 in Paris, France.
May 31, 2017© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now